Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Testing | 25 | 2024 | 3591 | 1.690 |
Why?
|
Genetic Variation | 25 | 2023 | 6611 | 1.090 |
Why?
|
Sequence Analysis, DNA | 14 | 2020 | 4780 | 1.040 |
Why?
|
Genome, Human | 19 | 2024 | 4441 | 0.970 |
Why?
|
Genomics | 24 | 2024 | 5924 | 0.940 |
Why?
|
Computational Biology | 10 | 2022 | 3567 | 0.730 |
Why?
|
Pathology, Molecular | 4 | 2022 | 328 | 0.700 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2020 | 3667 | 0.680 |
Why?
|
Noonan Syndrome | 2 | 2017 | 122 | 0.640 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2017 | 224 | 0.580 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2017 | 24 | 0.550 |
Why?
|
Genetic Predisposition to Disease | 24 | 2024 | 18063 | 0.540 |
Why?
|
Genetic Counseling | 5 | 2024 | 635 | 0.520 |
Why?
|
Databases, Genetic | 10 | 2021 | 1758 | 0.510 |
Why?
|
Software | 8 | 2020 | 4472 | 0.510 |
Why?
|
Information Dissemination | 5 | 2021 | 1142 | 0.490 |
Why?
|
Prion Diseases | 1 | 2016 | 99 | 0.470 |
Why?
|
Blood Group Antigens | 3 | 2022 | 183 | 0.470 |
Why?
|
GTP Phosphohydrolases | 2 | 2017 | 525 | 0.460 |
Why?
|
Prions | 1 | 2016 | 177 | 0.450 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2022 | 1337 | 0.440 |
Why?
|
Hyperlipoproteinemia Type II | 3 | 2024 | 396 | 0.430 |
Why?
|
Genetic Diseases, Inborn | 4 | 2020 | 606 | 0.400 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.400 |
Why?
|
Germ-Line Mutation | 3 | 2017 | 1885 | 0.390 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12790 | 0.380 |
Why?
|
Penetrance | 3 | 2023 | 388 | 0.340 |
Why?
|
Metamorphosis, Biological | 2 | 2009 | 38 | 0.340 |
Why?
|
Multifactorial Inheritance | 4 | 2024 | 1422 | 0.340 |
Why?
|
Disease | 3 | 2021 | 675 | 0.330 |
Why?
|
DNA Copy Number Variations | 2 | 2015 | 2047 | 0.330 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2020 | 64 | 0.320 |
Why?
|
Sexual Development | 1 | 2009 | 39 | 0.320 |
Why?
|
Antigens, Human Platelet | 2 | 2019 | 41 | 0.310 |
Why?
|
Blood Grouping and Crossmatching | 2 | 2019 | 99 | 0.310 |
Why?
|
Mutation, Missense | 3 | 2019 | 2592 | 0.300 |
Why?
|
Algorithms | 7 | 2019 | 14098 | 0.300 |
Why?
|
Laboratories | 3 | 2023 | 463 | 0.280 |
Why?
|
Biological Specimen Banks | 4 | 2021 | 787 | 0.280 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 12250 | 0.270 |
Why?
|
Hypercholesterolemia | 2 | 2024 | 1144 | 0.270 |
Why?
|
Workflow | 3 | 2022 | 859 | 0.260 |
Why?
|
Drosophila melanogaster | 3 | 2010 | 1722 | 0.260 |
Why?
|
Neonatal Screening | 4 | 2024 | 620 | 0.240 |
Why?
|
Genes, BRCA2 | 2 | 2017 | 591 | 0.230 |
Why?
|
Cardiomyopathies | 4 | 2020 | 2057 | 0.220 |
Why?
|
BRCA2 Protein | 2 | 2019 | 802 | 0.220 |
Why?
|
Genes, BRCA1 | 2 | 2017 | 753 | 0.220 |
Why?
|
Vinculin | 2 | 2020 | 58 | 0.210 |
Why?
|
Humans | 78 | 2024 | 767040 | 0.200 |
Why?
|
BRCA1 Protein | 2 | 2019 | 1155 | 0.200 |
Why?
|
Alleles | 4 | 2023 | 6893 | 0.200 |
Why?
|
Quality Improvement | 1 | 2017 | 3854 | 0.190 |
Why?
|
Pharmacogenetics | 3 | 2022 | 682 | 0.190 |
Why?
|
Risk Assessment | 4 | 2023 | 24299 | 0.190 |
Why?
|
Heart Diseases | 1 | 2014 | 2817 | 0.180 |
Why?
|
MNSs Blood-Group System | 1 | 2020 | 7 | 0.180 |
Why?
|
Membrane Proteins | 2 | 2017 | 7868 | 0.180 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2020 | 843 | 0.170 |
Why?
|
Genetics, Medical | 1 | 2023 | 334 | 0.170 |
Why?
|
Sexual Behavior, Animal | 2 | 2010 | 120 | 0.160 |
Why?
|
Genes, Insect | 2 | 2010 | 265 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
RNA, Messenger | 1 | 2013 | 12793 | 0.150 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2019 | 766 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2016 | 3797 | 0.150 |
Why?
|
Canada | 3 | 2021 | 2127 | 0.150 |
Why?
|
Research Design | 3 | 2020 | 6210 | 0.150 |
Why?
|
Electronic Health Records | 5 | 2018 | 4881 | 0.140 |
Why?
|
Gene Expression Profiling | 2 | 2010 | 9532 | 0.130 |
Why?
|
Herpes Zoster | 1 | 2018 | 252 | 0.130 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 388 | 0.130 |
Why?
|
Health | 1 | 2019 | 398 | 0.130 |
Why?
|
ABO Blood-Group System | 1 | 2018 | 381 | 0.130 |
Why?
|
Primary Health Care | 3 | 2023 | 4746 | 0.120 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 163 | 0.120 |
Why?
|
Infant, Newborn | 10 | 2024 | 26396 | 0.120 |
Why?
|
Government Programs | 1 | 2017 | 278 | 0.120 |
Why?
|
Guidelines as Topic | 2 | 2018 | 1396 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2024 | 16036 | 0.120 |
Why?
|
Exons | 1 | 2020 | 2391 | 0.110 |
Why?
|
Male | 33 | 2024 | 364203 | 0.110 |
Why?
|
ras Proteins | 1 | 2019 | 1054 | 0.110 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2014 | 61 | 0.110 |
Why?
|
Medical History Taking | 1 | 2017 | 779 | 0.110 |
Why?
|
Mutation | 5 | 2021 | 30211 | 0.110 |
Why?
|
Skin Diseases, Genetic | 1 | 2014 | 49 | 0.110 |
Why?
|
Science | 1 | 2016 | 234 | 0.110 |
Why?
|
Erythrocytes | 2 | 2019 | 2411 | 0.100 |
Why?
|
Communicable Diseases | 1 | 2021 | 872 | 0.100 |
Why?
|
Female | 34 | 2024 | 396660 | 0.100 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2014 | 94 | 0.100 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.100 |
Why?
|
Gene Deletion | 1 | 2020 | 2668 | 0.100 |
Why?
|
Arthrogryposis | 1 | 2013 | 69 | 0.100 |
Why?
|
Genotype | 6 | 2023 | 13035 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2698 | 0.100 |
Why?
|
Risk Factors | 10 | 2024 | 74886 | 0.100 |
Why?
|
Chromosome Aberrations | 2 | 2021 | 1776 | 0.100 |
Why?
|
Marfan Syndrome | 1 | 2014 | 237 | 0.100 |
Why?
|
Decision Trees | 1 | 2013 | 508 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1567 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 1 | 2012 | 474 | 0.090 |
Why?
|
Chromosome Mapping | 4 | 2021 | 4616 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 343 | 0.090 |
Why?
|
Rare Diseases | 1 | 2016 | 630 | 0.090 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4247 | 0.080 |
Why?
|
Base Sequence | 3 | 2017 | 12414 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2159 | 0.080 |
Why?
|
Pupa | 1 | 2009 | 42 | 0.080 |
Why?
|
Receptors, Steroid | 1 | 2009 | 157 | 0.080 |
Why?
|
Arteries | 1 | 2014 | 1123 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 951 | 0.080 |
Why?
|
Coronary Disease | 1 | 2023 | 5914 | 0.080 |
Why?
|
Genetic Association Studies | 4 | 2020 | 2744 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 8068 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4627 | 0.080 |
Why?
|
Vascular Malformations | 1 | 2014 | 469 | 0.080 |
Why?
|
Middle Aged | 19 | 2024 | 223233 | 0.070 |
Why?
|
Ion Channels | 1 | 2013 | 1043 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2024 | 3418 | 0.070 |
Why?
|
Mechanotransduction, Cellular | 1 | 2013 | 539 | 0.070 |
Why?
|
Ultrasonography, Prenatal | 1 | 2016 | 1772 | 0.070 |
Why?
|
Pedigree | 3 | 2020 | 4539 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15645 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2014 | 707 | 0.070 |
Why?
|
Adult | 18 | 2024 | 223317 | 0.070 |
Why?
|
Larva | 1 | 2009 | 512 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2605 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6573 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10393 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3236 | 0.070 |
Why?
|
Joint Instability | 1 | 2014 | 803 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 744 | 0.070 |
Why?
|
RNA Splicing | 2 | 2022 | 903 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20169 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2024 | 2353 | 0.060 |
Why?
|
Phenotype | 5 | 2022 | 16718 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2013 | 1178 | 0.060 |
Why?
|
Cohort Studies | 6 | 2024 | 41718 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2257 | 0.060 |
Why?
|
Epilepsy | 1 | 2019 | 3317 | 0.050 |
Why?
|
Gene Frequency | 2 | 2023 | 3621 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5180 | 0.050 |
Why?
|
Health Surveys | 1 | 2013 | 4056 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54886 | 0.050 |
Why?
|
Aged | 12 | 2024 | 171319 | 0.050 |
Why?
|
Heterozygote | 2 | 2020 | 2794 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8729 | 0.050 |
Why?
|
Duty to Recontact | 1 | 2021 | 19 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2009 | 2721 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2009 | 3610 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17608 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11097 | 0.050 |
Why?
|
Genetic Research | 1 | 2021 | 173 | 0.040 |
Why?
|
Biomedical Research | 1 | 2016 | 3464 | 0.040 |
Why?
|
Infant | 5 | 2024 | 36485 | 0.040 |
Why?
|
Heart Defects, Congenital | 2 | 2014 | 4713 | 0.040 |
Why?
|
Drosophila Proteins | 1 | 2009 | 1705 | 0.040 |
Why?
|
Young Adult | 6 | 2024 | 59980 | 0.040 |
Why?
|
North America | 1 | 2023 | 1287 | 0.040 |
Why?
|
Digestive System Diseases | 1 | 2021 | 152 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1733 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2021 | 59548 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2009 | 2647 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 255 | 0.040 |
Why?
|
DNA | 2 | 2022 | 7210 | 0.040 |
Why?
|
Pregnancy | 2 | 2017 | 30238 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11877 | 0.040 |
Why?
|
Mosaicism | 1 | 2021 | 480 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2020 | 22254 | 0.040 |
Why?
|
Pennsylvania | 1 | 2018 | 615 | 0.030 |
Why?
|
Galactosyltransferases | 1 | 2018 | 283 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 13085 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2018 | 437 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4401 | 0.030 |
Why?
|
Neoplasms | 2 | 2017 | 22350 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 315 | 0.030 |
Why?
|
SOS1 Protein | 1 | 2016 | 40 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 615 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5794 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 266 | 0.030 |
Why?
|
Disclosure | 1 | 2021 | 755 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2016 | 205 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 950 | 0.030 |
Why?
|
Informed Consent | 1 | 2021 | 1010 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21178 | 0.030 |
Why?
|
United States | 5 | 2023 | 72971 | 0.030 |
Why?
|
Counseling | 1 | 2023 | 1553 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1294 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2392 | 0.030 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 330 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 588 | 0.030 |
Why?
|
Desmoplakins | 1 | 2014 | 63 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1774 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 89046 | 0.030 |
Why?
|
Connective Tissue Diseases | 1 | 2016 | 285 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 104 | 0.030 |
Why?
|
Child | 5 | 2021 | 80771 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2013 | 240 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29963 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2017 | 4925 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 202 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11923 | 0.030 |
Why?
|
Hypolipidemic Agents | 1 | 2016 | 609 | 0.020 |
Why?
|
Haplotypes | 1 | 2018 | 2722 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 499 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1045 | 0.020 |
Why?
|
Age of Onset | 1 | 2019 | 3344 | 0.020 |
Why?
|
Incidental Findings | 1 | 2016 | 698 | 0.020 |
Why?
|
Time Factors | 2 | 2010 | 40154 | 0.020 |
Why?
|
Decision Making | 1 | 2024 | 3951 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2013 | 793 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4054 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 12158 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1907 | 0.020 |
Why?
|
Hearing Loss | 1 | 2016 | 785 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1666 | 0.020 |
Why?
|
Dissection | 1 | 2010 | 298 | 0.020 |
Why?
|
Olfactory Receptor Neurons | 1 | 2009 | 95 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14672 | 0.020 |
Why?
|
Family | 1 | 2019 | 3210 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9660 | 0.020 |
Why?
|
Insect Proteins | 1 | 2009 | 253 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1761 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4114 | 0.020 |
Why?
|
Blood Platelets | 1 | 2018 | 2464 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2058 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1966 | 0.020 |
Why?
|
Health Behavior | 1 | 2017 | 2650 | 0.020 |
Why?
|
Lipids | 1 | 2016 | 3322 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12536 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2824 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42606 | 0.010 |
Why?
|
Head | 1 | 2010 | 926 | 0.010 |
Why?
|
Health Personnel | 1 | 2018 | 3387 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2017 | 3618 | 0.010 |
Why?
|
Health Care Costs | 1 | 2017 | 3239 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5456 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8732 | 0.010 |
Why?
|
Brain | 1 | 2010 | 27163 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3232 | 0.010 |
Why?
|
Animals | 3 | 2010 | 168965 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14766 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 13048 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15925 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6966 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15851 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 81659 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15567 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26325 | 0.010 |
Why?
|